Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company researches, develops, manufactures, markets, and exports anti tuberculosis drugs.
Maneesh Pharmaceuticals Limited, is an unlisted public company incorporated on 25 July, 1985. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 30.00 cr and the total paid-up capital is INR 28.13 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2021 numbers.
-0.86%
-1.55%
-123.78%
-7.14%
-48.05%
-15.94%
0.75
-0.13
-20.78
-37.45
-9.33
-0.04
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(12)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Export-Import Bank of India
No. of Loans: 1
Total Amount : 18.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Maneesh Ramakant Sapte
Shareholder
|
00020450 | 22 years |
| Director | Vinay Ramakant Sapte
Shareholder
|
00135085 | 39 years |
| Director | Rashmi Vinay Sapte
Shareholder
|
00334247 | 18 years |
| CFO | Rakesh Khetan Tunaram | <HIDDEN> | 10 years |
| Director | Pravin Mohandas Hegde | 01404954 | 8 years |
| Director | Ajit Gopal Jamkhandikar | 08196191 | 6 years |
| CS | Chetan Shyamlal Chandwani | <HIDDEN> | 2 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| BOMBAY BIOSYNTEX CHEMICALS PRIVATE LIMIT ED |
Amalgamated
|
1.0 L | 2 | Maharashtra |
| SVIZERA PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
| SERVAC PHARMA (I) PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| PHAARMASIA LIMITED |
Active
|
6.8 Cr | 5 | Telangana |
| SHANBAG STORAGE AND SERVICES PRIVATE LIM ITED |
Amalgamated
|
25.0 L | 2 | Maharashtra |
| ADHRIT EDUCATION PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 2 | Maharashtra |
| PURE HEALTH PRODUCTS PRIVATE LIMITED |
Active
|
45.5 L | 2 | Maharashtra |
| MANTECH COUNTING AND SYSTEMS PRIVATE LIMITED |
Converted to LLP
|
3.8 L | 2 | Maharashtra |
| SVIZERA PHARMATECH PRIVATE LIMITED |
Strike Off
|
0.0 | 2 | Maharashtra |
| SVIZERA LABS PRIVATE LIMITED |
Active
|
2.8 Cr | 4 | Maharashtra |
| SVIZERA HEALTH REMEDIES PRIVATE LIMITED |
Converted to LLP
|
99.2 L | 2 | Maharashtra |
| HERITAGE LABORATORIES PRIVATE LIMITED |
Amalgamated
|
24.6 L | 2 | Himachal Pradesh |
| SHANBAG STORAGE AND SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| ADHRIT EDUCATION LLP |
Active
|
1.0 L | 2 | Maharashtra |
| SVIZERA HEALTH REMEDIES LLP |
Active
|
99.2 L | 2 | Maharashtra |
| PHARMANOVA SPECIALTIES PRIVATE LIMITED |
Active
|
5.2 Cr | 2 | Maharashtra |
| ERGOS LIFE SCIENCES PRIVATE LIMITED |
Active
|
61.0 Cr | 2 | Maharashtra |
| FAROMED LIFESCIENCES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| MANTECH COUNTING AND SYSTEMS LLP |
Active
|
3.8 L | 2 | Maharashtra |
| SVIZERA HEALTHCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| CARDEX LIFECARE LLP |
Active
|
1.0 L | 1 | Maharashtra |
| MASTER MIND PROPERTY PRIVATE LIMITED |
Active
|
1.6 L | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| ERGOS LIFE SCIENCES PRIVATE LIMITED | Maharashtra | 2017 | ₹ 61.0 Cr |
| PHAARMASIA LIMITED | Telangana | 1981 | ₹ 6.8 Cr |
| SVIZERA LABS PRIVATE LIMITED | Maharashtra | 1997 | ₹ 2.8 Cr |
| PURE HEALTH PRODUCTS PRIVATE LIMITED | Maharashtra | 1988 | ₹ 45.5 L |
| PHARMANOVA SPECIALTIES PRIVATE LIMITED | Maharashtra | 2014 | ₹ 5.2 Cr |
| SVIZERA PHARMA PRIVATE LIMITED | Maharashtra | 2000 | ₹ 10.0 L |
| SHANBAG STORAGE AND SERVICES PRIVATE LIMITED | Maharashtra | 2010 | ₹ 1.0 L |
The incorporation date of MANEESH PHARMACEUTICALS LIMITED is 25 July, 1985
The authorized share capital of MANEESH PHARMACEUTICALS LIMITED is INR ₹ 30.0 Cr.
The paid-up capital of MANEESH PHARMACEUTICALS LIMITED is INR ₹ 28.1 Cr.
The registered address of MANEESH PHARMACEUTICALS LIMITED is 29/33 , Ancillary Industrial Plots, Govandi Mumbai Mumbai City Maharashtra - 400043
The CIN number of MANEESH PHARMACEUTICALS LIMITED is U24230MH1985PLC036952.
Expand
Delete
Collapse
See
details
